Implementing a Screening Tool for Identifying Patients at Risk for Hereditary Breast and Ovarian Cancer: A Statewide Initiative

被引:29
|
作者
Traxler, L. Brannon [1 ]
Martin, Monique L. [2 ]
Kerber, Alice S. [2 ]
Bellcross, Cecelia A. [3 ]
Crane, Barbara E. [4 ]
Green, Victoria [5 ]
Matthews, Roland [6 ]
Paris, Nancy M. [2 ]
Gabram, Sheryl G. A. [1 ,7 ]
机构
[1] Emory Univ, Dept Surg, Atlanta, GA 30322 USA
[2] Georgia Ctr Oncol Res & Educ, Atlanta, GA USA
[3] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA
[4] Georgia Dept Publ Hlth, Atlanta, GA USA
[5] Emory Univ, Dept Obstet & Gynecol, Atlanta, GA 30322 USA
[6] Morehouse Sch Med, Dept Obstet & Gynecol, Atlanta, GA 30310 USA
[7] Grady Mem Hosp, Atlanta, GA USA
关键词
RECOMMENDATION STATEMENT; WOMEN; SUSCEPTIBILITY; MODEL;
D O I
10.1245/s10434-014-3921-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The Georgia Breast Cancer Genomic Health Consortium is a partnership created with funding from the Centers for Disease Control and Prevention (CDC) to the Georgia Department of Public Health to reduce cancer disparities among high-risk minority women. The project addresses young women at increased risk for hereditary breast and ovarian cancer (HBOC) syndrome through outreach efforts. Methods. The consortium provides education and collects surveillance data using the breast cancer genetics referral screening tool (B-RST) available at www.BreastCancerGeneScreen.org. The HBOC educational protocol was presented to 73 staff in 6 public health centers. Staff used the tool during the collection of medical history. Further family history assessments and testing for mutations in the BRCA1/2 genes were facilitated if appropriate. Results. Data was collected from November 2012 through December 2013, including 2,159 screened women. The majority of patients identified as black/African American and were 18-49 years old. Also, 6.0 % (n = 130) had positive screens, and 60.9 % (n = 67) of the 110 patients who agreed to be contacted provided a detailed family history. A total of 47 patients (42.7 %) met National Comprehensive Cancer Network guidelines when family history was clarified. Fourteen (12.7 %) underwent genetic testing; 1 patient was positive for a BRCA2 mutation, and 1 patient was found to carry a variant of uncertain significance. Conclusions. The introduction of genomics practice within public health departments has provided access to comprehensive cancer care for uninsured individuals. The successful implementation of the B-RST into public health centers demonstrates the opportunity for integration of HBOC screening into primary care practices.
引用
收藏
页码:3342 / 3347
页数:6
相关论文
共 50 条
  • [1] Implementing a Screening Tool for Identifying Patients at Risk for Hereditary Breast and Ovarian Cancer: A Statewide Initiative
    L. Brannon Traxler
    Monique L. Martin
    Alice S. Kerber
    Cecelia A. Bellcross
    Barbara E. Crane
    Victoria Green
    Roland Matthews
    Nancy M. Paris
    Sheryl G. A. Gabram
    [J]. Annals of Surgical Oncology, 2014, 21 : 3342 - 3347
  • [2] Implementing a Screening Tool for Identifying Patients at Risk for Breast and Ovarian Cancer: A Statewide Initiative
    Traxler, Lucy Brannon
    Martin, Monique L.
    Kerber, Alice S.
    Bellcross, Cecelia A.
    Crane, Barbara E.
    Green, Victoria
    Matthews, Roland
    Gabram, Sheryl
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 118 - 118
  • [3] Screening for Individuals at Risk for Hereditary Breast and Ovarian Cancer: A Statewide Initiative, Georgia, 2012-2020
    Veitinger, Julia K.
    Kerber, Alice S.
    Gabram-Mendola, Sheryl G. A.
    Liu, Yuan
    Durham, Lynn M.
    Durrence, Diane
    Berzen, Alissa K.
    Shin, Janet Y.
    Snyder, Cindy
    Bellcross, Cecelia A.
    Guan, Yue
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2022, 112 (09) : 1249 - 1252
  • [4] Identifying and managing hereditary risk of breast and ovarian cancer
    Frank, TS
    Critchfield, GC
    [J]. CLINICS IN PERINATOLOGY, 2001, 28 (02) : 395 - +
  • [5] Identifying Patients at Risk for Hereditary Breast Cancer
    Olbrys, Kathleen M.
    [J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2013, 9 (01): : 66 - 67
  • [6] Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening
    Hoskins, Kent F.
    Zwaagstra, Alice
    Ranz, Michael
    [J]. CANCER, 2006, 107 (08) : 1769 - 1776
  • [7] Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study
    Maria C. Katapodi
    Deb Duquette
    James J. Yang
    Kari Mendelsohn-Victor
    Beth Anderson
    Christos Nikolaidis
    Emily Mancewicz
    Laurel L. Northouse
    Sonia Duffy
    David Ronis
    Kara J. Milliron
    Nicole Probst-Herbst
    Sofia D. Merajver
    Nancy K. Janz
    Glenn Copeland
    Scott Roberts
    [J]. Cancer Causes & Control, 2017, 28 : 191 - 201
  • [8] Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study
    Katapodi, Maria C.
    Duquette, Deb
    Yang, James J.
    Mendelsohn-Victor, Kari
    Anderson, Beth
    Nikolaidis, Christos
    Mancewicz, Emily
    Northouse, Laurel L.
    Duffy, Sonia
    Ronis, David
    Milliron, Kara J.
    Probst-Herbst, Nicole
    Merajver, Sofia D.
    Janz, Nancy K.
    Copeland, Glenn
    Roberts, Scott
    [J]. CANCER CAUSES & CONTROL, 2017, 28 (03) : 191 - 201
  • [9] Prevention and Screening in Hereditary Breast and Ovarian Cancer
    Zeichner, Simon B.
    Stanislaw, Christine
    Meisel, Jane L.
    [J]. ONCOLOGY-NEW YORK, 2016, 30 (10): : 896 - 904
  • [10] Genetic testing for patients at risk of hereditary breast and ovarian cancer
    DeTroye, Alisha
    Gabbett, Kayla
    Yi, Cheryl
    Judice, Melanie
    Luu, Victor
    Nelson, Brittany
    Gregory, Tanya
    [J]. JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (10): : 48 - 52